Amphastar Pharmaceuticals Inc vs Crowdstrike Holdings Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Crowdstrike Holdings Inc trades at $218.92 (market cap $225.95B). The key difference: Crowdstrike Holdings Inc is far larger — about 260.1× Amphastar Pharmaceuticals Inc's market cap, and Crowdstrike Holdings Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | CRWD | |
|---|---|---|
Market Cap | $868.62M | $225.95B |
Sector | Health | Technology |
52-Week High | $30.81 | $225.16 |
52-Week Low | $16.87 | $87.56 |
Enterprise Value | $1.27B | $222.22B |
Trailing returns across standard periods
Latest headlines on both assets
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →CrowdStrike Holdings provides cybersecurity products and services aimed at protecting organizations from cyberthreats. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, identity protection, and log management. CrowdStrike went public in 2019 and serves customers worldwide.
Read more on CRWD →